Answer
Yes, NovoEight factor VIII replacement therapy may increase cardiovascular risk in patients with existing cardiovascular risk factors.
Sources for this answer
- NovoEight 1500 IU powder and solvent for solution for injectionNovo Nordisk Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked